Natera, Inc. has announced the appointment of Eric Rubin to its Board of Directors, effective March 26, 2026. This decision comes as part of the company's strategic move to expand its Board from ten to eleven members. Dr. Rubin will serve as a Class I director, with his term set to expire at the 2028 annual meeting of stockholders. The Board's decision was based on the recommendation of its Nominating, Corporate Governance and Compliance Committee. Dr. Rubin's appointment is significant as he qualifies as an independent director under the Securities Act of 1933 and the listing standards of The Nasdaq Stock Market. He will also join the Nominating, Corporate Governance and Compliance Committee of the Board. In connection with his appointment, Dr. Rubin will receive compensation consistent with that of the company's other non-employee directors, as outlined in the Amended Compensation Program for Non-Employee Directors. This includes an initial equity award that will vest over three years. The company has also entered into an Indemnification Agreement with Dr. Rubin, ensuring his protection against legal claims related to his service. This leadership change is expected to enhance the governance structure of Natera, potentially leading to improved operational execution and strategic outlook.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.